Companies House does not verify the accuracy of the information filed

KINIKSA PHARMACEUTICALS (UK), LTD.

Company number 11716038

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
09 Dec 2024	CS01	Confirmation statement made on 5 December 2024 with updates	View PDF Confirmation statement made on 5 December 2024 with updates - link opens in a new window - 5 pages (5 pages)
06 Oct 2024	AA	Full accounts made up to 31 December 2023	View PDF Full accounts made up to 31 December 2023 - link opens in a new window - 40 pages (40 pages)
20 Aug 2024	TM01	Termination of appointment of Ross Michael Moat as a director on 1 August 2024	View PDF Termination of appointment of Ross Michael Moat as a director on 1 August 2024 - link opens in a new window - 1 page (1 page)
02 Jul 2024	PSC07	Cessation of Kiniksa Pharmaceuticals, Ltd. as a person with significant control on 27 June 2024	View PDF Cessation of Kiniksa Pharmaceuticals, Ltd. as a person with significant control on 27 June 2024 - link opens in a new window - 1 page (1 page)
02 Jul 2024	PSC02	Notification of Kiniksa Pharmaceuticals International, Plc as a person with significant control on 27 June 2024	View PDF Notification of Kiniksa Pharmaceuticals International, Plc as a person with significant control on 27 June 2024 - link opens in a new window - 2 pages (2 pages)
17 May 2024	SH19	Statement of capital on 17 May 2024 GBP 4	View PDF Statement of capital on 17 May 2024 GBP 4 - link opens in a new window - 5 pages (5 pages)
17 May 2024	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
17 May 2024	CAP-SS	Solvency Statement dated 12/05/24	View PDF Solvency Statement dated 12/05/24 - link opens in a new window - 2 pages (2 pages)
17 May 2024	RESOLUTIONS	Resolutions RES13 ‐ Reduce share premium 13/05/2024	View PDF Resolutions RES13 ‐ Reduce share premium 13/05/2024 - link opens in a new window - 2 pages (2 pages)
12 Jan 2024	CS01	Confirmation statement made on 5 December 2023 with no updates	View PDF Confirmation statement made on 5 December 2023 with no updates - link opens in a new window - 3 pages (3 pages)
02 Jan 2024	RESOLUTIONS	Resolutions RES13 ‐ Waive and release of kiniksa pharmaceuticals LTD of any and all claims against the shareholder and all liabilities the shareholder has/ deed of release 21/11/2023	View PDF Resolutions RES13 ‐ Waive and release of kiniksa pharmaceuticals LTD of any and all claims against the shareholder and all liabilities the shareholder has/ deed of release 21/11/2023 - link opens in a new window - 2 pages (2 pages)
04 Dec 2023	SH19	Statement of capital on 4 December 2023 GBP 4	View PDF Statement of capital on 4 December 2023 GBP 4 - link opens in a new window - 3 pages (3 pages)
04 Dec 2023	RESOLUTIONS	Resolutions RES13 ‐ Reduction of share premium account/amount credited to distributable reserve/the sum of $45,000,000 paid as distribution 21/11/2023	View PDF Resolutions RES13 ‐ Reduction of share premium account/amount credited to distributable reserve/the sum of $45,000,000 paid as distribution 21/11/2023 - link opens in a new window - 2 pages (2 pages)
04 Dec 2023	CAP-SS	Solvency Statement dated 20/11/23	View PDF Solvency Statement dated 20/11/23 - link opens in a new window - 2 pages (2 pages)
04 Dec 2023	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
12 Oct 2023	AA	Full accounts made up to 31 December 2022	View PDF Full accounts made up to 31 December 2022 - link opens in a new window - 36 pages (36 pages)
22 Aug 2023	RP04SH01	Second filing of a statement of capital following an allotment of shares on 11 October 2022 GBP 4	View PDF Second filing of a statement of capital following an allotment of shares on 11 October 2022 GBP 4 - link opens in a new window - 4 pages (4 pages)
22 Aug 2023	RP04SH01	Second filing of a statement of capital following an allotment of shares on 21 February 2022 GBP 4	View PDF Second filing of a statement of capital following an allotment of shares on 21 February 2022 GBP 4 - link opens in a new window - 4 pages (4 pages)
17 Mar 2023	TM01	Termination of appointment of Sanjiv Patel as a director on 17 February 2023	View PDF Termination of appointment of Sanjiv Patel as a director on 17 February 2023 - link opens in a new window - 1 page (1 page)
07 Jan 2023	AA	Accounts for a small company made up to 31 December 2021	View PDF Accounts for a small company made up to 31 December 2021 - link opens in a new window - 34 pages (34 pages)
05 Jan 2023	CS01	Confirmation statement made on 5 December 2022 with updates	View PDF Confirmation statement made on 5 December 2022 with updates - link opens in a new window - 4 pages (4 pages)
22 Dec 2022	SH01	Statement of capital following an allotment of shares on 11 October 2022 GBP 4 ANNOTATION Clarification a second filed SH01 was registered on 22/08/2023	View PDF Statement of capital following an allotment of shares on 11 October 2022 GBP 4 ANNOTATION Clarification a second filed SH01 was registered on 22/08/2023 - link opens in a new window - 4 pages (4 pages)
22 Dec 2022	SH01	Statement of capital following an allotment of shares on 21 February 2022 GBP 4 ANNOTATION Clarification a second filed SH01 was registered on 22/08/2023	View PDF Statement of capital following an allotment of shares on 21 February 2022 GBP 4 ANNOTATION Clarification a second filed SH01 was registered on 22/08/2023 - link opens in a new window - 4 pages (4 pages)
10 Mar 2022	AD03	Register(s) moved to registered inspection location Suite 2 First Floor 10 Temple Back Bristol BS1 6FL	View PDF Register(s) moved to registered inspection location Suite 2 First Floor 10 Temple Back Bristol BS1 6FL - link opens in a new window - 1 page (1 page)
10 Mar 2022	AD02	Register inspection address has been changed to Suite 2 First Floor 10 Temple Back Bristol BS1 6FL	View PDF Register inspection address has been changed to Suite 2 First Floor 10 Temple Back Bristol BS1 6FL - link opens in a new window - 1 page (1 page)

Cookies on Companies House services

KINIKSA PHARMACEUTICALS (UK), LTD.

Filter by category